Target intelligence / Profile preview

Nuclear RNA export factor 2 (NXF2)

Target
NXF2
Molecular classification
RNA-binding protein, Nucleocytoplasmic transport protein, Cancer/testis antigen
01

Overview

Nuclear RNA export factor 2 (NXF2) is an RNA-binding and nucleocytoplasmic transport protein involved in exporting mRNAs from the nucleus and regulating their localization and metabolism in the cytoplasm. As a member of the NXF family, NXF2 is structurally similar to NXF1 but is distinguished by testis-specific expression under normal physiology and by functioning as a cancer/testis antigen in cancers such as acute leukemia. NXF2 interacts with nucleoporins and cytoplasmic motor proteins to mediate both nuclear export and cytoplasmic mRNA trafficking. It is epigenetically silenced in most somatic tissues but can be reactivated by hypomethylating drugs like decitabine, which makes it a potential immunotherapy target in hematologic malignancies. NXF2 has also been implicated in male infertility due to its role in germ cell RNA export and function

Other names
TCP11X2TAPL-2CT39TAPL2Cancer/testis antigen 39TAP-like protein 2t-complex protein 11 homolog
02

Mechanism of action

Demethylating agents (such as decitabine) upregulate NXF2 by reversing CpG island hypermethylation, allowing NXF2 to be expressed in certain cancer cells and potentially targeting it for immunotherapy

03

Biological functions

mRNA nuclear exportCytoplasmic mRNA localizationPost-transcriptional regulation of mRNA metabolism
04

Disease associations

Cancer (notably acute leukemia, potentially lung cancer)Male infertility (nonobstructive azoospermia)
05

Safety considerations

Potential for off-target immune responses due to presence of cancer/testis antigens in normal germ cellsNeed for careful specificity in immunotherapeutic targeting to avoid adverse effects on fertility or germ cell biology
06

Interacting drugs

Decitabine
07

Biomarkers

NXF2 expression (as a biomarker for response to hypomethylating therapy in acute leukemia)

Beyond the preview

Go deeper on Nuclear RNA export factor 2 (NXF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear RNA export factor 2 (NXF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call